Stewart Fisher has been promoted to chief scientific officer of C4 Therapeutics. Fisher joined Watertown, MA-based C4 in 2016 as senior vice president of discovery sciences. Before working at C4, Fisher held positions at the Broad Institute and AstraZeneca (NYSE: [[ticker:AZN]]). C4 emerged in 2016 with a $73 million Series A round of financing to develop drugs based on the ubiquitin-proteasome system, a system that cells use to get rid of unwanted proteins.
Author: Frank Vinluan
Xconomy Editor Frank Vinluan is a business journalist with experience covering technology and life sciences. Based in Raleigh, he was a staff writer at the Triangle Business Journal covering technology, biotechnology and energy before joining MedCityNews.com as North Carolina bureau chief. Prior to moving to North Carolina’s Research Triangle in 2007 he held business reporting positions at The Des Moines Register and The Seattle Times.
View all posts by Frank Vinluan
